Dolby Laboratories, Inc. (DLB)
NYSE: DLB · Real-Time Price · USD
62.10
+0.33 (0.53%)
At close: Aug 10, 2026, 4:00 PM EDT
61.56
-0.54 (-0.87%)
Pre-market: Aug 11, 2026, 8:09 AM EDT
Dolby Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 26, 2026 | Sep '25 Sep 26, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 24, 2021 |
Net Income | 281.68 | 256.49 | 264.32 | 201.64 | 183.9 | 317.82 |
Depreciation & Amortization | 116.99 | 87.83 | 75.56 | 82.56 | 88.46 | 95.86 |
Stock-Based Compensation | 167.15 | 128.51 | 119.83 | 118.49 | 114.93 | 99.7 |
Other Adjustments | 34.16 | 16.38 | -13.74 | 11.48 | -12.45 | -40.99 |
Change in Receivables | -120.02 | -1.78 | -37.67 | 48.13 | -8.01 | -70.19 |
Changes in Inventories | 10.51 | 8.02 | -2.65 | -13.23 | -11.76 | 17.15 |
Changes in Accounts Payable | 151.02 | 22.85 | -34.55 | -52.32 | -33.54 | 44.23 |
Changes in Income Taxes Payable | -43.1 | -42.83 | -4.5 | -8.72 | 8.45 | -2.98 |
Changes in Unearned Revenue | -2.4 | -5.08 | -9.74 | -8.38 | -0.41 | 2.36 |
Changes in Other Operating Activities | -87.44 | 1.81 | -29.59 | -12.57 | -10.97 | -15.22 |
Operating Cash Flow | 492.4 | 472.2 | 327.25 | 367.08 | 318.58 | 447.75 |
Operating Cash Flow Growth | 5.77% | 44.29% | -10.85% | 15.23% | -28.85% | 30.22% |
Capital Expenditures | -49.55 | -36.35 | -30.01 | -30.34 | -47.93 | -54.45 |
Sale of Property, Plant & Equipment | - | 16.88 | - | - | - | 16.37 |
Purchases of Intangible Assets | -48.92 | -5.59 | - | - | -11.53 | - |
Proceeds from Sale of Intangible Assets | 16.62 | - | - | - | - | - |
Purchases of Investments | - | -0.08 | -160.2 | -172.96 | -316.31 | -67.1 |
Proceeds from Sale of Investments | - | 15.91 | 391.79 | 231.8 | 118.01 | 64.79 |
Cash Acquisitions | - | -1.36 | -487.88 | 25.7 | -38.17 | -4.5 |
Investing Cash Flow | -75.3 | -10.59 | -286.29 | 54.21 | -295.94 | -44.91 |
Issuance of Common Stock | 43.95 | 43.7 | 40.93 | 47.78 | 57.85 | 122.09 |
Repurchase of Common Stock | -371.4 | -162.23 | -199.08 | -180.42 | -566.9 | -278.07 |
Net Common Stock Issued (Repurchased) | -327.45 | -118.53 | -158.15 | -132.64 | -509.06 | -155.98 |
Common Dividends Paid | -168.59 | -126.6 | -114.58 | -103.41 | -100.07 | -89.17 |
Other Financing Activities | -2.04 | -2.11 | -15.08 | -0.77 | -1.44 | -7.36 |
Financing Cash Flow | -498.62 | -247.24 | -287.81 | -236.81 | -610.56 | -252.52 |
Foreign Exchange Rate Adjustments | -1.95 | 1.24 | 6.64 | 5.12 | -16.74 | 2.72 |
Net Cash Flow | -83.47 | 215.61 | -240.21 | 189.6 | -604.66 | 153.05 |
Free Cash Flow | 442.84 | 435.85 | 297.25 | 336.74 | 270.65 | 393.3 |
Free Cash Flow Growth | 1.09% | 46.63% | -11.73% | 24.42% | -31.19% | 41.73% |
FCF Margin | 32.70% | 32.31% | 23.34% | 25.91% | 21.59% | 30.70% |
Free Cash Flow Per Share | 4.61 | 4.47 | 3.05 | 3.45 | 2.65 | 3.76 |
Levered Free Cash Flow | 322.19 | 291.27 | 226.34 | 157.67 | 176.38 | 397.18 |
Unlevered Free Cash Flow | 292.99 | 260.18 | 183.02 | 130.99 | 168.78 | 395.7 |